Correction of morphological abnormalities |
Depending on underlying condition: |
N/A |
N/A |
N/A |
Prolapse, cloaca, keyhole deformity, perirectal fistula, rectovaginal fistula, tumor |
Sphincter repair |
Overlapping sphincteroplasty |
75%-85% (short term) |
N/A |
|
0-50% (after 5-10 yr) |
Enhancement of sphincter function |
Sacral nerve stimulation |
0%-56%/51-100% |
lead displacement (15%), diarrhea (6%), pain (6-28%), bleeding 11%, infection (3%) |
1B |
Tibial nerve simulation |
0%-12% (-40%)/0%-67% |
59% (infection, mild gastrodynia, temporary leg numbness) |
2C |
Radiofrequency energy administration |
0%/12%-38% (-84%) |
0%-52% (pain, bleeding, infection) |
2B |
Injection of: |
0%/33%-90% |
10%-12% (pain, bleeding, infection) |
2A |
conventional bulking agents |
6%/56%-61% |
NASHA/DX |
|
Sphincter replacement |
Artificial bowel sphincter |
61%-90%/31%-100% |
5%-10% infection rates, 30%-52% long-term failure 9 |
1B |
Implantation of magnetic ring (Fenix™) |
NA/54% |
0%-7% obstruction, infection, erosion |
1C |
Graciloplasty (dynamic/non-dynamic) |
NA/72% |
> 40% including urinary tract infection/retention, infections 76 |
2C |
Implantation of Thiersch |
N/A |
N/A |
N/A |
Pelvic floor repairs/sling |
19%/69.1% |
17%-30% (pain, infection) |
2C |
Fecal diversion |
Ileostomy, loop colostomy, end colostomy |
near 100% FI improvement |
5%-10% stoma outlet obstruction, stricture, prolapse, hernia |
1C |
Fecal load reduction |
Malone antegrade continence enema |
(0%)/33%-100% FI continence |
8%-50% stoma stenosis, leakage |
2C |